Gain Therapeutics, Inc. (GANX) vs Hyperfine, Inc. (HYPR)
A side-by-side comparison of Gain Therapeutics, Inc. and Hyperfine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GANX
Gain Therapeutics, Inc.
$1.74HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
HYPR
Hyperfine, Inc.
$0.91HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — GANX vs HYPR
growth of $100 · dividends reinvested · last 6yGANX -84.9% (-27.0%/yr)HYPR -91.1% (-33.2%/yr)GANX compounded faster over this window
GANX HYPR
GANX vs HYPR: by the numbers
- •HYPR is the larger company ($76M vs $74M market cap).
- •Both run net losses; GANX's is the smaller (0.00% vs -210.75% net margin).
Metrics side by side
Valuation
| Metric | GANX | HYPR |
|---|---|---|
| P/S ratio | N/A | 4.62 |
| P/B ratio | 6.55 | 2.08 |
Profitability
| Metric | GANX | HYPR |
|---|---|---|
| Gross margin | 0.00% | 51.41% |
| Operating margin | 0.00% | -273.43% |
| Net margin | 0.00% | -210.75% |
| ROE | -178.06% | -94.81% |
| ROIC | -159.24% | -62.98% |
Growth (annualized)
| Metric | GANX | HYPR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 77.73% |
| Total return CAGR (5Y) | -25.06% | -38.34% |
Frequently asked
- How have GANX and HYPR total returns compared?
- Over the past 5 years, GANX delivered -25.06% and HYPR delivered -38.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Gain Therapeutics ROEHyperfine ROEGain Therapeutics operating marginHyperfine operating marginGain Therapeutics revenue growthHyperfine revenue growthGain Therapeutics free cash flowHyperfine free cash flow
Gain Therapeutics & Hyperfine appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.